Summary & Overview
HCPCS A4255: Platforms for Home Blood Glucose Monitor, 50 per Box
HCPCS Level II code A4255 designates platforms for home blood glucose monitors supplied in boxes of 50. This durable medical supply supports self-monitoring for patients with diabetes and other conditions requiring glucose surveillance. Nationally, provision of standardized supplies like platforms affects patient access to self-care, supply chain management, and payer coverage policies for diabetes management.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of how A4255 is characterized in billing and supply contexts, common payer considerations, and typical sites of service. The publication summarizes benchmark themes such as coverage scope for home glucose supplies, reimbursement constructs used by major payers, and implications for clinical workflows and supply ordering.
The report provides: a clear definition of the code and service type; the typical clinical and operational settings where the platforms are used; common modifiers and administrative elements associated with billing (listed separately); and guidance on what information is and is not available in the input. Data not available in the input includes associated taxonomies, specific ICD-10 pairings, and comparative reimbursement rates.
Billing Code Overview
HCPCS Level II code A4255 describes platforms for home blood glucose monitor, 50 per box. The service type is durable medical supply for self-monitoring of blood glucose. The typical site of service is home or other outpatient/home-based settings where patients use personal blood glucose monitoring equipment.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with diabetes mellitus who requires routine home blood glucose monitoring supplies. The clinician prescribes platforms for home blood glucose monitors (50 per box) to support capillary glucose testing at home for glycemic control, medication titration, or hypoglycemia management. The clinical workflow begins with a diabetes follow-up visit in an outpatient clinic or primary care office where history, medication regimen, and self-monitoring needs are reviewed. The clinician documents the medical necessity for providing testing platforms, writes a durable medical equipment/supply prescription specifying A4255 (platforms for home blood glucose monitor, 50 per box), and transmits the order to a durable medical equipment (DME) supplier or in-office supply dispenser. The supplier verifies patient eligibility with payors such as Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, BUCA, or Medicare, applies appropriate modifiers for billing, and ships supplies to the patient’s home or makes them available for pick-up in the clinic. Typical sites of service include outpatient clinic, physician office, and the patient’s home. Common scenarios include routine diabetes self-management supplies for type 1 diabetes, type 2 diabetes on insulin or sulfonylurea therapy, pregnancy with gestational diabetes requiring home glucose monitoring, or newly diagnosed diabetes requiring initiation of a monitoring regimen.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
NU |